Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-29T08:38:47.373Z Has data issue: false hasContentIssue false
  • English
  • Français

Chorea in the Elderly with Mutation Positive Polycythemia Vera: A Case Report

Published online by Cambridge University Press:  02 December 2014

Hrishikesh Kumar ,
Paul Masiowski  and
Mandar Jog
Hrishikesh Kumar
Affiliation:
Movement Disorder Program, London Health Sciences Centre, London Ontario, Canada
Paul Masiowski
Affiliation:
Movement Disorder Program, London Health Sciences Centre, London Ontario, Canada
Mandar Jog*
Affiliation:
Movement Disorder Program, London Health Sciences Centre, London Ontario, Canada
*
Movement Disorder Program, London Health Sciences Centre, 339, Windermere Road, London, Ontario, N6A 5A5, Canada
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Brief Communications
Information
Canadian Journal of Neurological Sciences , Volume 36 , Issue 3 , May 2009 , pp. 370 - 372
Copyright
Copyright © The Canadian Journal of Neurological 2009

References

1. Wild, EJ, Tabrizi, SJ. The differential diagnosis of chorea. Pract Neurol. 2007 Nov;7(6):360–73.Google Scholar
2. Cardoso, F, Seppi, K, Mair, KJ, Wenning, GK, Poewe, W. Seminars on choreas. Lancet Neurol. 2006 Jul;5(7):589–602.CrossRefGoogle ScholarPubMed
3. Kilpivaara, O, Levine, RL. JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and science. Leukemia. 2008 Oct;22(10):1813–7.Google Scholar
4. Finazzi, G, Barbui, T. The treatment of polcythemia vera: an update in the JAK2 era. Intern Emerg Med. 2007 March;2(1):13–8.Google Scholar
5. Tefferi, A, Thiele, J, Orazi, A, Kvasnicka, HM, Barbui, T, Hanson, CA, et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood. 2007 Aug 15;110(4):1092–7.Google Scholar
6. Umney, WF. Notes on a fatal case of splenomegalic polycythemia. Lancet. 1909;I:1243–5.Google Scholar
7. Bordachzi, P. Chorea und polycythemia vera. Prag Med Wochr. 1909;34:253.Google Scholar
8. Cohen, AM, Gelvan, A, Yarmolovsky, A, Djaldetti, M. Chorea in polycythemia vera: a rare presentation of hyperviscosity. Blut. 1989 Jan;58(1):47–8.CrossRefGoogle ScholarPubMed
9. Voiculescu, V, Ionescu, DA, Lazar, G, Alecu, C, Predescu, C, Popa, C, et al. Two cases of choreatic syndrome caused by polycythemia vera. Eur Neurol. 1979;18(2):96–100.CrossRefGoogle ScholarPubMed
10. Mas, JL, Gueguen, B, Bouche, P, Derouesné, C, Varet, B, Castaigne, P. Chorea and polycythaemia. J Neurol. 1985;232(3):169–71.CrossRefGoogle ScholarPubMed
11. Bruyn, GW, Padberg, G. Chorea and polycythaemia. Eur Neurol. 1984;23(1):26–33.CrossRefGoogle ScholarPubMed
12. Morré, HH, van Woerkom, TC, Endtz, LJ. A case of chorea due to polycythaemia vera. Clin Neurol Neurosurg. 1982;84(2):125–30.CrossRefGoogle ScholarPubMed
13. Borg-Costanzi, JM, Mohr, PD, Lewis, D. Primary polycythaemia presenting with chorea. Postgrad Med J. 1981 Apr;57(666):228–31.Google Scholar
14. Nazabal, ER, Lopez, JM, Perez, PA, Del Corral, PR. Chorea disclosing deterioration of polycythaemia. Postgrad Med J. 2000 Oct;76:658–9.CrossRefGoogle ScholarPubMed
15. Midi, I, Dib, H, Köseoglu, M, Afsar, N, Günal, DI. Hemichorea associated with polycythaemia vera. Neurol Sci. 2006 Dec;27(6):439–41.CrossRefGoogle ScholarPubMed
16. Edwards, PD, Prosser, R, Wells, CE. Chorea, polycythaemis, and cyanotic heart disease. J Neurol Neurosurg Psychiatry. 1975 Aug;38(8):729–39.Google Scholar
17. Kim, W, Kim, JS, Lee, KS, Kim, YI, Park, CW, Chung, YA. No evidence of perfusion abnormalities in the basal ganglia of a patient with generalized chorea-ballism and polycythaemia vera: analysis using subtraction SPECT co-registered to MRI. Neurol Sci. 2008 Oct;29(5):351–4.CrossRefGoogle ScholarPubMed
18. Kotner, LM, Tritt, JH. Chorea complicating polycythemia vera: report of a case. Ann Int Med. 1942;17: 544–8.Google Scholar
19. D’agostino, AN, Pease, GL, Kernohan, FW. Cerebral demyelination associated with polycythemia vera. J Neuropathol Exp Neurol. 1963 Jan;22:138–47.Google Scholar
20. Landolfi, R, Di Gennaro, L, Falalngo, A. Thrombocytosis in myeloproliferative disorders: pathogenetic facts and speculation. Leukemia. 2008 Nov;22(11):2020–8.Google Scholar
21. Landolfi, R, Cipriani, MC, Novarese, L. Thrombosis and bleeding in polycythemia vera and essential thrombocythemia: pathogenic mechanism and prevention. Best Pract Res Clin Haematol. 2006;19(3):617–33.Google Scholar
22. Finazzi, G, Barbui, T. Evidence and expertise in the management of polycythemia vera and essential thrombocythemia. Leukemia. 2008 Aug;22(8):1494–502.Google Scholar
23. Pardanani, A, Hood, J, Lasho, T, Levine, RL, Martin, MB, Noronha, G, et al. TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2 V617F and MPL515L/K mutations. Leukemia. 2007;21:1658–68.Google Scholar